InceptionR’s Ocular Therapeutix OCUL Stock Holding History

InceptionR’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,087	Closed	-$69K	–	807
2024 Q2	$69K	Buy	+10,087	New	+$62.3K	0.02%	553

Other funds holding OCUL

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

InceptionR's OCUL Position: Q3 2024 in Review

InceptionR sold out of Ocular Therapeutix (OCUL) in Q3 2024, closing a stake of 10,087 shares — an estimated $69K sold.

InceptionR first reported a position in OCUL in Q2 2024 and held it in 1 quarter. The position peaked at $69K in Q2 2024. 168 funds tracked by Wall St. Rank hold OCUL as of Q3 2024.

InceptionR reported no remaining Ocular Therapeutix position as of Q3 2024 after selling out during the quarter.
InceptionR sold 10,087 Ocular Therapeutix shares in Q3 2024, an estimated $69K.
InceptionR first reported a position in Ocular Therapeutix in Q2 2024 and held it in 1 quarter.
InceptionR's Ocular Therapeutix position peaked at $69K in Q2 2024.
168 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2024.

Based on InceptionR's 13F filing for Q3 2024, filed 8 Nov 2024.